IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq ... Mr. Michel served as Chief Financial Officer at Vericel Corporation, a biopharmaceutical company. Mr. Michel also served as ...

Falcon Finance, a next-generation synthetic dollar protocol, has officially reached its first $100 million Total Value Locked (TVL) milestone during its Closed Beta phase. The controlled rollout ...